top of page
2013 International Autism Conference

2013 ICare4Autism International Autism Conference

​

Autism: Cutting Edge Research and Promising Treatment Approaches
 
ICare4Autism Conference at Albert Einstein College of Medicine Attracts Over 300 People
Download the Conference Program Booklet
​

NEW YORK, NY–(Marketwired – Jun 7, 2013) – On June 5, 2013 the International Center for Autism Research and Education (ICare4Autism) held the conference, “Autism: Cutting Edge Research and Promising Treatment Approaches,” at Albert Einstein College of Medicine in conjunction with Montefiore Medical Center.

From neurology to psychology and everything in between, the speakers presented studies on the many aspects of autism research and treatment methods. Dr. Eric Hollander, Director of the Autism and Obsessive-Compulsive Spectrum Disorders Program at Albert Einstein College of Medicine/Montefiore Medical Center and Chairman of the ICare4Autism Advisory Council, discussed Inflammation, Temperature and Personalized Therapeutics of ASD.

Dr. Theoharis C. Theoharides at 2013 International Autism Conference

Dr. Theoharis C. Theoharides of Tufts University School of Medicine discussing mast cell activation syndrome

Martha Herbert, M.D., Ph.D., of Harvard Medical School and the Massachusetts General Hospital, presented her research, Taking a Fresh Look at Autism: Chronic Dynamic State, not Fixed Trait. Dr. Herbert is the Director of the TRANSCEND Research Program (Treatment Research and Neuroscience Evaluation of Neurodevelopmental Disorders) with key interests in the concept of autism as a “dynamic encephalopathy (changeable) rather than a static encephalopathy (fixed for life).”

Dr. Gary Steinman, Chairman of the Department of Biochemistry at Touro College of Osteopathic Medicine, presented Diagnosis and Treatment of Autism at Birth. Dr. Steinman’s studies suggest the potential for addressing autism

by looking at the role of depressed IGF (insulin-like growth factor) at birth.

He is collaborating internationally to develop a protocol for early identification of autism.

Non-verbal until age 4 and diagnosed with autism himself, Dr. Stephen Shore of Adelphi University presented Special Ways and Techniques (SWAT) for Achieving Meaningful Inclusion. Dr. Shore is a self-advocate who promotes early intervention and educational strategies to embrace difference and access learned knowledge through unconventional, yet creative and effective, means.

Other presenters included Dr. Carlos A. Pardo, Dr. Theoharis C. Theoharides, Dr. Aleksandra Djukic, Dr. Nathaniel Heintz, Dr. Sophie Molholm and Dr. Alisa G. Woods.

Dr. Eric Hollander, Chairman of the ICare4Autism Advisory Council at 2013 International Autism Conference

Dr. Eric Hollander, Chairman of the ICare4Autism Advisory Council, presenting his studies on the effects of oxytocin in ASD

Founder and CEO of ICare4Autism, Dr. Joshua Weinstein at 2013 International Autism Conference

Timetable

8:30-9:00am   

Welcoming Remarks:
Joshua Weinstein, Ph.D., M.B.A.  
Founder & CEO of ICare4Autism, Shema Kolainu – Hear Our Voices, School and Center for Children with Autism and TISHMA, ABA Center for Children with Autism, USA and Israel

Eric Hollander, M.D. 
Director of the Autism Spectrum Program at Albert Einstein College of Medicine/Montefiore Medical Center and Chairman of the ICare4Autism Advisory Council

Bruce J. Schwartz, M.D. Deputy Chairman & Clinical Director, Professor of Clinical Psychiatry, Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center

Founder and CEO of ICare4Autism, Dr. Joshua Weinstein, discussing the Global Autism Center which will be opening in 2017 on Mount Scopus in Jerusalem

9:00-9:45am
Keynote Address:

Martha Herbert, M.D., Ph.D.
Assistant Professor of Neurology at Harvard Medical School, Pediatric Neurologist at the Massachusetts General Hospital in Boston, Director of the TRANSCEND Research Program (Treatment Research and Neuroscience Evaluation of Neurodevelopmental Disorders)
Taking a Fresh Look at Autism: Chronic Dynamic State, not Fixed Trait

​

10:00-10:30am
Carlos A. Pardo, M.D.
Associate Professor, Department of Neurology and Pathology, Johns Hopkins University School of Medicine
Exploring the Immune-Brain Interactions in Autism: A Look at Cytokines-Chemokines

Networks 

​

10:30–11:00am
Nathaniel Heintz, Ph.D.
Investigator, Howard Hughes Medical Institute, James and Marilyn Simons Professor, Laboratory of Molecular Biology, The Rockefeller University
A role for 5-hydroxymethylcytosine in ASD?

Steven Solender, Dr. Theoharis C. Theoharides, Dr. Gary Steinman, Dr. Alisa G. Woods, Dr. Eric Hollander, Dr. Martha Herbert, Lee Grossman, Dr. Stephen Shore, Dr. Joshua Weinstein Founder & CEO of ICare4Autism, Jacqueline Aidenbaum, Dr. Carlos A. Pardo and Dr. Beth Diviney at the VIP Conference Luncheon

Steven Solender, Dr. Theoharis C. Theoharides, Dr. Gary Steinman, Dr. Alisa G. Woods, Dr. Eric Hollander, Dr. Martha Herbert, Lee Grossman, Dr. Stephen Shore, Dr. Joshua Weinstein Founder & CEO of ICare4Autism, Jacqueline Aidenbaum, Dr. Carlos A. Pardo and Dr. Beth Diviney at the VIP Conference Luncheon

11:00–11:30am
Theoharis C. Theoharides, M.S., Ph.D., M.D., FAAAAI 
Professor of Pharmacology, Internal Medicine and Biochemistry; Director, Molecular Immunopharmacology and Drug Discovery Laboratory; Dept of Molecular Physiology and Pharmacology, Tufts University School of Medicine
Activated Mast Cells Secrete “Innate Pathogens” Causing Focal Brain Inflammation Reversed by methoxyluteolin

​

11:30–12:00am
Aleksandra Djukic, M.D., PhD.
Director, Tri-State Rett Syndrome Center, Associate Professor of Neurology and Pediatrics, Montefiore Medical Center, Albert Einstein College of Medicine
Communication Deficits in Rett’s Syndrome

​

12:00–12:30pm
Eric Hollander, M.D. 
Director of the Autism Spectrum Program at Albert Einstein College of Medicine/Montefiore Medical Center and Chairman of the ICare4Autism Advisory Council 
Inflammation, Temperature and Personalized Therapeutics of ASD

​

12:30–1:30pm Lunch on your own

​

1:30–2:00pm 
Stephen Shore, Ed.D. 
Assistant Professor, Dept. of Special Education, Adelphi University, member of the ICare4Autism Advisory Council
Special Ways and Techniques (SWAT) for Achieving Meaningful Inclusion

2:00–2:30pm
Alisa G Woods, Ph.D., M.S
Director, Autism Research Program, Laboratory for Biochemistry and Proteomics, Clarkson University
Protein Biomarkers in Autism Spectrum Disorders

​

2:30–3:00pm
Sophie Molholm, Ph.D.
Associate Professor, Muriel and Harold Block Faculty Scholar in Mental Illness, Departments of Pediatrics and Neuroscience, The Sheryl and Daniel R. Tishman Cognitive Neurophysiology Laboratory, Albert Einstein College of Medicine

​

3:00–3:30pm
Gary Steinman, M.D., Ph.D. 
Chairman, Dept. of Biochemistry, Touro College of Osteopathic Medicine 
Diagnosis and Treatment of Autism at Birth

Founder of ICare4Autism, Dr. Joshua Weinstein, with Advisory Committee Member Dr. Beth Diviney and Dr. Eric Hollander, Chairman of the ICare4Autism Advisory Committee

Founder of ICare4Autism, Dr. Joshua Weinstein, with Advisory Committee Member Dr. Beth Diviney and Dr. Eric Hollander, Chairman of the ICare4Autism Advisory Committee

3:30–4:00pm
Daniel Orlievsky
Director, Outreach Program about Language Habilitation Through Writing in Autism, Professor of Child Psychology and Co-Director of Research Projects: Writing and Language in Autism, School of Psychology, University of Buenos Aires, Argentina
Language, Writing and Conduct Disorder in the Autistic Spectrum

​

4:00–4:30pm
Joshua Weinstein, Ph.D., M.B.A.  
Founder & CEO of ICare4Autism, Shema Kolainu – Hear Our Voices, School and Center for Children with Autism and TISHMA, ABA Center for Children with Autism, USA and Israel
ICare4Autism Global Autism Initiatives

The conference had leading experts from biomedical and educational/behavioral fields speaking on the latest advances in autism research, education and policies. It was a gathering place for leading international autism researchers to work in collaboration, and converse about the latest autism education, research, treatments and best practices. It was sponsored by Albert Einstein College of Medicine and co-sponsored by Shema Kolainu-Hear Our Voices, Montefiore Medical Center and Coronado BioSciences.

Speakers presented either on new research findings that they are most passionate about or best practices that work effectively for people with ASD and their families.

The program included an international roster of acclaimed speakers on cutting edge research and clinical topics. Representing ICare4Autism was Dr. Joshua Weinstein, the Founder & CEO of ICare4Autism, Dr. Eric Hollander, Director of the Autism and Obsessive Compulsive Spectrum Program at Albert Einstein College of Medicine/Montefiore Medical Center and Chair of the ICare4Autism Advisory Council, and Stephen Shore, Ed. D., Assistant Professor, Dept. of Special Education, Adelphi University, and member of the ICare4Autism Advisory Council.

​
What were the Benefits of Attending?
  • Listen to leading experts presenting the latest international research and developments in the field of Autism.

  • Learn practical approaches to supporting people with ASD.

  • Network with professional colleagues from around the world.

  • Get fresh information to help inspire families affected by an Autism Spectrum Disorder.

 
Who attended?
  • Education and teaching professionals

  • Psychologists, speech pathologists, occupational therapists and other allied occupations

  • Academics and students Health Professionals, including pediatricians, psychiatrists, neurologists, geneticists, etc.

  • Chief Executive Officers, directors and senior managers who provide services to children and adults with Autism. Families and care-givers of people with Autism.

bottom of page